BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Waluga M, Kukla M, Żorniak M, Bacik A, Kotulski R. From the stomach to other organs: Helicobacter pylori and the liver. World J Hepatol 2015; 7(18): 2136-2146 [PMID: 26328025 DOI: 10.4254/wjh.v7.i18.2136] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Lupu A, Miron IC, Cianga AL, Cernomaz AT, Lupu VV, Gavrilovici C, Stârcea IM, Tarca E, Ghica DC, Fotea S. The Prevalence of Liver Cytolysis in Children with Helicobacter pylori Infection. Children (Basel) 2022;9:1498. [PMID: 36291434 DOI: 10.3390/children9101498] [Reference Citation Analysis]
2 Gu C, Zhou Z, Yu Z, He M, He L, Luo Z, Xiao W, Yang Q, Zhao F, Li W, Shen L, Han J, Cao S, Zuo Z, Deng J, Yan Q, Ren Z, Zhao M, Yu S. The Microbiota and It’s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease. Front Cell Infect Microbiol 2022;12:870785. [DOI: 10.3389/fcimb.2022.870785] [Reference Citation Analysis]
3 Wang L, Cao ZM, Zhang LL, Dai XC, Liu ZJ, Zeng YX, Li XY, Wu QJ, Lv WL. Helicobacter Pylori and Autoimmune Diseases: Involving Multiple Systems. Front Immunol 2022;13:833424. [PMID: 35222423 DOI: 10.3389/fimmu.2022.833424] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Wang Z, Wang W, Gong R, Yao H, Fan M, Zeng J, Xu S, Lin R. Eradication of Helicobacter pylori alleviates lipid metabolism deterioration: a large-cohort propensity score-matched analysis. Lipids Health Dis 2022;21. [DOI: 10.1186/s12944-022-01639-5] [Reference Citation Analysis]
5 Bulur O, Aksoy EK, Güler Şimşek G, Eser M, Asiltürk Lülleci Z, Dal K, Uzman M. The Relationship Between Severity of Gastric Inflammation Due to Helicobacter pylori and Colorectal Malignancies. Cumhuriyet Medical Journal 2021. [DOI: 10.7197/cmj.980147] [Reference Citation Analysis]
6 Man S, Ma Y, Jin C, Lv J, Tong M, Wang B, Li L, Ning Y. Association between Helicobacter pylori Infection and Diabetes: A Cross-Sectional Study in China. J Diabetes Res 2020;2020:7201379. [PMID: 33062714 DOI: 10.1155/2020/7201379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Hata K, Koyama T, Ozaki E, Kuriyama N, Mizuno S, Matsui D, Watanabe I, Uehara R, Watanabe Y. Assessing the Relationship between Helicobacter pylori and Chronic Kidney Disease. Healthcare (Basel) 2021;9:162. [PMID: 33546229 DOI: 10.3390/healthcare9020162] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 李 婷. The Mechanism of Nonalcoholic Fatty Liver Disease Induced by Helicobacter pylori Infection. ACM 2021;11:3865-3869. [DOI: 10.12677/acm.2021.119566] [Reference Citation Analysis]
9 Okovity SV, Raikhelson KL, Volnukhin AV, Kudlai DA. Hepatoprotective properties of glycyrrhizic acid. jour 2020. [DOI: 10.31146/1682-8658-ecg-184-12-96-108] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Li S, Wu D, Cao M, Yu Z, Wu M, Liu Y, Zhou J, Yan S, Chen J, Huang M, Zhao J. Effects of choline supplementation on liver biology, gut microbiota, and inflammation in Helicobacter pylori-infected mice. Life Sci 2020;259:118200. [PMID: 32758621 DOI: 10.1016/j.lfs.2020.118200] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
11 Santos MLC, de Brito BB, da Silva FAF, Sampaio MM, Marques HS, Oliveira e Silva N, de Magalhães Queiroz DM, de Melo FF. Helicobacter pylori infection: Beyond gastric manifestations. World J Gastroenterol 2020; 26(28): 4076-4093 [PMID: 32821071 DOI: 10.3748/wjg.v26.i28.4076] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
12 Chen C, Zhang C, Wang X, Zhang F, Zhang Z, Ma P, Feng S. Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome. Eur J Gastroenterol Hepatol 2020;32:857-66. [PMID: 31714387 DOI: 10.1097/MEG.0000000000001601] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
13 Abdel-Razik A, Mousa N, Elhelaly R, Elzehery R, Hasan AS, Abdelsalam M, Seif AS, Tawfik AM, El-Wakeel N, Eldars W. Helicobacter pylori as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study. Front Med (Lausanne) 2020;7:96. [PMID: 32266280 DOI: 10.3389/fmed.2020.00096] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
14 Yu L, Wang L, Yi H, Wu X. Beneficial effects of LRP6-CRISPR on prevention of alcohol-related liver injury surpassed fecal microbiota transplant in a rat model. Gut Microbes 2020;11:1015-29. [PMID: 32167008 DOI: 10.1080/19490976.2020.1736457] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
15 Abo-Amer YE, Sabal A, Ahmed R, Hasan NFE, Refaie R, Mostafa SM, Mohamed AA, Khalil M, Elagawy W, Abd-Elsalam S. Relationship Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study. Diabetes Metab Syndr Obes 2020;13:619-25. [PMID: 32184641 DOI: 10.2147/DMSO.S237866] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
16 Yao CC, Kuo CM, Hsu CN, Yang SC, Wu CK, Tai WC, Liang CM, Wu KL, Huang CF, Bi KW, Lee CH, Chuah SK. First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus. Infect Drug Resist 2019;12:1425-31. [PMID: 31239721 DOI: 10.2147/IDR.S194584] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
17 Elsebaey MA, Tawfik MA, Elshweikh SA, Negm MS, Elnaggar MH, Alghazaly GM, Abd-Elsalam S. Impact of Helicobacter pylori Infection on Gastric Variceal Bleeding among Patients with Liver Cirrhosis. Gastroenterol Res Pract 2019;2019:6529420. [PMID: 30881448 DOI: 10.1155/2019/6529420] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
18 Wojciech Łapiński T. The Importance of H. pylori Infection in Liver Diseases. Helicobacter pylori [Working Title] 2018. [DOI: 10.5772/intechopen.79969] [Reference Citation Analysis]
19 Katsiki N, Mikhailidis DP, Mantzoros C. Non-alcoholic fatty liver disease and colorectal cancer: A marker of risk or common causation? Metabolism 2018;87:A10-3. [DOI: 10.1016/j.metabol.2018.08.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
20 German SV, Bobrovnitsky IP. Helicobacter pylori Infection and Hepatobiliary Pathology. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2018;28:15-22. [DOI: 10.22416/1382-4376-2018-28-4-15-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Okushin K, Tsutsumi T, Ikeuchi K, Kado A, Enooku K, Fujinaga H, Moriya K, Yotsuyanagi H, Koike K. Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis. World J Gastroenterol 2018; 24(32): 3617-3625 [PMID: 30166857 DOI: 10.3748/wjg.v24.i32.3617] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
22 Gravina AG, Zagari RM, De Musis C, Romano L, Loguercio C, Romano M. Helicobacter pylori and extragastric diseases: A review. World J Gastroenterol 2018; 24(29): 3204-3221 [PMID: 30090002 DOI: 10.3748/wjg.v24.i29.3204] [Cited by in CrossRef: 132] [Cited by in F6Publishing: 124] [Article Influence: 33.0] [Reference Citation Analysis]
23 Lu LJ, Hao NB, Liu JJ, Li X, Wang RL. Correlation between Helicobacter pylori Infection and Metabolic Abnormality in General Population: A Cross-Sectional Study. Gastroenterol Res Pract 2018;2018:7410801. [PMID: 29743888 DOI: 10.1155/2018/7410801] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
24 Cherkas A, Zarkovic K, Cipak Gasparovic A, Jaganjac M, Milkovic L, Abrahamovych O, Yatskevych O, Waeg G, Yelisyeyeva O, Zarkovic N. Amaranth oil reduces accumulation of 4-hydroxynonenal-histidine adducts in gastric mucosa and improves heart rate variability in duodenal peptic ulcer patients undergoing Helicobacter pylori eradication. Free Radic Res 2018;52:135-49. [PMID: 29251014 DOI: 10.1080/10715762.2017.1418981] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
25 Cherkas A, Golota S, Guéraud F, Abrahamovych O, Pichler C, Nersesyan A, Krupak V, Bugiichyk V, Yatskevych O, Pliatsko M, Eckl P, Knasmüller S. A Helicobacter pylori-associated insulin resistance in asymptomatic sedentary young men does not correlate with inflammatory markers and urine levels of 8-iso-PGF2-α or 1,4-dihydroxynonane mercapturic acid. Arch Physiol Biochem 2018;124:275-85. [PMID: 29105496 DOI: 10.1080/13813455.2017.1396346] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
26 Pogorzelska J, Łapińska M, Kalinowska A, Łapiński TW, Flisiak R. Helicobacter pylori infection among patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2017;29:1161-5. [PMID: 28700364 DOI: 10.1097/MEG.0000000000000928] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
27 Kazakova MA, Pozdeev OK, Valeeva YV, Morozova LG, Fayzullina RA. Species spectrum of microflora of upper digestive tract mucosa and its effect on the development of pathology in children. Kazan Med J 2017;98:557-563. [DOI: 10.17750/kmj2017-557] [Reference Citation Analysis]
28 Huang J, Cui J. Evaluation of Helicobacter pylori Infection in Patients with Chronic Hepatic Disease. Chin Med J (Engl). 2017;130:149-154. [PMID: 28091405 DOI: 10.4103/0366-6999.197980] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
29 Setiawan VW, Wei PC, Hernandez BY, Lu SC, Monroe KR, Marchand LL, Yuan JM. Reply to High hepatocellular carcinoma risk among US-born Hispanics. Cancer 2017;123:358-9. [PMID: 27741358 DOI: 10.1002/cncr.30396] [Reference Citation Analysis]
30 Porras D, Nistal E, Martínez-flórez S, Pisonero-vaquero S, Olcoz JL, Jover R, González-gallego J, García-mediavilla MV, Sánchez-campos S. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Free Radical Biology and Medicine 2017;102:188-202. [DOI: 10.1016/j.freeradbiomed.2016.11.037] [Cited by in Crossref: 255] [Cited by in F6Publishing: 265] [Article Influence: 51.0] [Reference Citation Analysis]
31 Sripa B, Deenonpoe R, Brindley PJ. Co-infections with liver fluke and Helicobacter species: A paradigm change in pathogenesis of opisthorchiasis and cholangiocarcinoma? Parasitol Int 2017;66:383-9. [PMID: 27919744 DOI: 10.1016/j.parint.2016.11.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
32 Lecube A, Valladares S, López-Cano C, Gutiérrez L, Ciudin A, Fort JM, Reñé JM, Matias-Guiu X, de Torres I, Bueno M, Pallarés J, Baena JA. The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori. PLoS One 2016;11:e0166741. [PMID: 27893763 DOI: 10.1371/journal.pone.0166741] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
33 Wang J, Chen RC, Zheng YX, Zhao SS, Li N, Zhou RR, Huang Y, Huang ZB, Fan XG. Helicobacter pylori infection may increase the risk of progression of chronic hepatitis B disease among the Chinese population: a meta-analysis. Int J Infect Dis 2016;50:30-7. [PMID: 27457918 DOI: 10.1016/j.ijid.2016.07.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
34 Tsai CE, Liang CM, Lee CH, Kuo YH, Wu KL, Chiu YC, Tai WC, Chuah SK. First-line Helicobacter pylori eradication among patients with chronic liver diseases in Taiwan. Kaohsiung J Med Sci 2016;32:397-402. [PMID: 27523452 DOI: 10.1016/j.kjms.2016.05.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
35 Cai YL, Zhang KG. Clinical value of detection of anti-Helicobacter pylori antibody in urine. Shijie Huaren Xiaohua Zazhi 2016; 24(16): 2513-2519 [DOI: 10.11569/wcjd.v24.i16.2513] [Reference Citation Analysis]